Elanco Animal Health Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Great. So good afternoon, everyone. Thank you for joining us. This is Dave Risinger. And I cover both major and specialty pharmaceuticals at Morgan Stanley. I need to refer you to disclaimers at www.morganstanley.com/researchdisclosures. And if you're a member of the press, please disconnect and contact the Morgan Stanley Public relations office.
So I am very pleased to welcome Jeff Simmons, who is the CEO of Elanco. As the Head of Elanco Animal Health for the past decade, he's directed the company's transformation into a premier global player, now 2, #2 in the business. With a balance of diversified businesses, Jeff has overseen the completion of 12 acquisitions, built 5 new businesses, including the $1 billion-plus Companion Animal business, and also a leading aquaculture operation. So we're very pleased to have Jeff with us today. Jeff, let me turn it over to you for some opening
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
